Antiinfective biotechs face partnering gap.
Sheridan
Cormac
C
D000890:Anti-Infective Agents / Q000191:economics*; D001709:Biotechnology / Q000458:organization & administration*; D004345:Drug Industry / Q000458:organization & administration*; D007373:Interinstitutional Relations; D007449:Investments / Q000458:organization & administration*; D010067:Ownership / Q000458:organization & administration*; D014481:United States
D000890:Anti-Infective Agents